Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Brown Brandon Louis Sr.SVP, Chief Accounting Officer | Option exercise | M | — 1,000 sh | Sep 3, 2026 |
| 9 | Brown Michael AugustSVP, GC & Corp. Secretary | Grant or award | A | — 335 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Jani RaviChief Financial Officer | Disposition to issuer | D | — 248 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Bliss KellyPresident, U.S. Group Health | Option exercise | M | — 4,859 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Ellingson Alan WayneChief Financial Officer | Option exercise | M | — 5,300 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Swiniarski Keith C.Chief Accounting Officer | Tax withholding | F | $790 121 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Fiedler RyanChief Financial Officer | Grant or award | A | — 6,859 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Fiedler RyanChief Financial Officer | Grant or award | A | — 2,817 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Parrish DeanEVP & Chief Operating Officer | Option exercise | M | — 1,000 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Jani RaviChief Financial Officer | Option exercise | M | — 437 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Beaven Peter DavidDirector | Grant or award | A | — 1,092 sh | Sep 3, 2026 traded Sep 2, 2026 |
| 9 | Swiniarski Keith C.Chief Accounting Officer | Option exercise | M | — 500 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Hottinger TysonChief Legal Officer | Grant or award | A | — 10.6K sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Parrish DeanEVP & Chief Operating Officer | Tax withholding | F | $4,153 289 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Parrish DeanEVP & Chief Operating Officer | Option exercise | M | — 1,000 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 8 | Randhawa SimratEVP, Head of R&D | Open-market sale · 10b5-1 plan | SELL | $273K 2,600 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 8 | Sousa Mauad BrunoDirector | Derivative conversion | C | $406K 4,999 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 8 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $37K 858 sh | Sep 3, 2026 traded Sep 3, 2026 |
| 8 | Sousa Mauad BrunoDirector | Derivative conversion | C | $649K 24.2K sh | Sep 3, 2026 traded Sep 1, 2026 |
| 8 | Ellingson Alan WayneChief Financial Officer | Tax withholding | F | $60K 2,563 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 8 | Mulligan BrendanGeneral Counsel and Secretary | Tax withholding | F | $259K 9,435 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Randhawa SimratEVP, Head of R&D | Option exercise · 10b5-1 plan | M | $134K 7,500 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Rodrigues Fernando M.President of BetterHelp | Option exercise · 10b5-1 plan | M | — 1,042 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Randhawa SimratEVP, Head of R&D | Option exercise · 10b5-1 plan | M | $136K 6,249 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Viljoen NataschaDirector, President & CEO | Open-market sale · 10b5-1 plan | SELL | $477K 3,882 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Rodrigues Fernando M.President of BetterHelp | Option exercise · 10b5-1 plan | M | — 8,717 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Guarini KathrynDirector | Option exercise · 10b5-1 plan | M | — 400 sh | Sep 3, 2026 traded Sep 2, 2026 |
| 7 | Smith Kevin P.EVP, Bus Dev, GC & Sec | Tax withholding · 10b5-1 plan | F | $46K 8,671 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Colburn Richard Edward IIIChief Product & Tech Officer | Open-market sale · 10b5-1 plan | SELL | $40K 479 sh | Sep 3, 2026 traded Sep 3, 2026 |
| 7 | Le Pendeven YvesCFO | Open-market sale · 10b5-1 plan | SELL | $12K 1,833 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Randhawa SimratEVP, Head of R&D | Option exercise · 10b5-1 plan | M | $207K 9,375 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 6 | Verma ShivChief Financial Officer | Option exercise | M | — 9,692 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 6 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $59K 1,368 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 6 | Verma ShivChief Financial Officer | Option exercise | M | — 23.6K sh | Sep 3, 2026 traded Sep 1, 2026 |
| 6 | Kerdman AlinaSVP, Controller & CAO | Option exercise | M | — 408 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 6 | Yoon William TChief Legal Officer | Grant or award | A | — 28.9K sh | Sep 3, 2026 traded Sep 1, 2026 |
| 6 | Tuffin PaulaGeneral Counsel and CCO | Grant or award | A | — 6,132 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 6 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $193K 600 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 6 | Kerdman AlinaSVP, Controller & CAO | Tax withholding | F | $13K 206 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 5 | Ellingson Alan WayneChief Financial Officer | Option exercise | M | — 2,140 sh | Sep 3, 2026 traded Sep 1, 2026 |